Industry Practices: Suppressing Safety Concerns

Dr. Josef Witt-Doerring's journey, spanning from his time at the FDA to his transition into the pharmaceutical industry and eventual establishment of a private practice, is marked by its uniqueness. His commitment to vocalizing his concerns and upholding ethical standards challenges the traditional practices often associated with his field.

Dr. Josef Witt-Doerring is a psychiatrist who specializes in tapering patients off psychiatric medications. Over the last four years he has helped hundreds of patients successfully stop their psychiatric medications. He is a trained expert in psychiatric medicine and in the identification and treatment of adverse drug reactions. Dr. Witt-Doerring has also had the privilege of helping several patients with litigation related to psychiatric drug injuries. 

Witt-Doerring Psychiatry

Dr. Josef: Social Media and Professional Links

Note: This podcast episode is designed solely for informational and educational purposes, without endorsing or promoting any specific medical treatments. We strongly advise consulting with a qualified healthcare professional before making any medical decisions or taking any actions.

*If you are in crisis or believe you have an emergency, please contact your doctor or dial 911. If you are contemplating suicide, call 1-800-273-TALK to speak with a trained and skilled counselor.

RADICALLY GENUINE PODCAST

Dr. Roger McFillin / Radically Genuine Website

YouTube @RadicallyGenuine

Dr. Roger McFillin (@DrMcFillin) / X (Twitter)

Substack | Radically Genuine | Dr. Roger McFillin

Instagram @radicallygenuine

Contact Radically Genuine

—-----------

FREE DOWNLOAD! DISTRESS TOLERANCE SKILLS

—----------

ADDITIONAL RESOURCES

2:00 - Dr. Josef Witt-Doerring Open Letter to Psychiatric and Family Medicine Colleagues

23:30 - Patient Health Questionnaire (PHQ-9 & PHQ-2)

24:00 - Enduring pain: how a 1996 opioid policy change had long-lasting effects

24:30 - Liability and Patient Suicide - PMC

25:00 - Reframing the Key Questions Regarding Screening for Suicide Risk | Depressive Disorders | JAMA

28:00 - The Treatment for Adolescents With Depression Study (TADS): Long-term Effectiveness and Safety Outcomes

30:30 - Accutane: iPLEDGE

41:00 - PDUFA VII: Fiscal Years 2023 – 2027 | FDA

49:00 - Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

51:00 - Dr. Josef YouTube: Antidepressants Nearly Ruined my Marriage

1:02:00 - David Healy: Post-SSRI Sexual Dysfunction | RxISK

1:08:00 - Antidepressants and Mass Shootings/Murder Suicide: An interview with Dr. David Healy

1:13:00 - Your Consent is Not Required - Rob Wipond

1:46:00 - The Coddling of the American Mind: How Good Intentions and Bad Ideas Are Setting Up a Generation for Failure: Lukianoff, Greg, Haidt, Jonathan